Expression of cholera toxin B subunit in Saccharomyces cerevisiae

Annals of Microbiology

Volumn 55, Issue 2, 2005, Pages 145-150

  Arzanlou, Mohsen ^a   Rezaee, Abbas ^a,d   Shahrokhi, Nader ^b   Hossini, Ahmad Zavaran ^a   Yasuda, Yoko ^c   Tochikubo, Kunio ^c   Ahangarzadeh Rezaee, Mohammad ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^d NONE   (Iran)

Author keywords

CTB; Gene expression; Saccharomyces cerevisiae; Vibrio cholera

Indexed keywords

SACCHAROMYCES CEREVISIAE; VIBRIO CHOLERAE;

EID: 21244433606     PISSN: 15904261     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. st edn., National Academic Press, Washington D.C., USA.
2. Arakawa T., Chong D.K.X., Langridge W.H.R. (1998). Efficacy of a food plant-based oral cholera toxin B subunit vaccine. Nat. Biotech., 16: 292-297.
3. Arakawa T., Chong D.K.X., Merritt J.L., Langridge W.H.R. (1997). Expression of cholera toxin B subunit oligomers in transgenic potato plants. Trans. Res., 6: 403-413.
4. Bradford M.M. (1976). A rapid and sensitive method for quantitation of microgram quantities of protein utilising the principle of protein dye binding. Anal. Biochem., 72: 248-254
5. Daniell H., Lee S.B., Panchal T., Wiebe P.O. (2001). Expression of native cholera toxin B subunit gene assembly as functional oligomers in transgenic tobacco chloroplasts. J. Mol. Biol., 311: 1001-1009.
6. Deresiewicz R.L., Calderwood S.B., Robertus J.D., Collier R.J. (1992). Mutations affecting the activity of the shiga-like toxin I A-Chain. Infect. Immun., 31: 3272-3280.
7. Deresiewicz R.L., Flaxenburg J.A., Chan M., Finberg R.B. (1994). Intracellular expression of toxic shock syndrome toxin 1 in Saccharomyces cerevisiae. Infect. Immun., 62: 2202-2207.
8. Haq T.A., Mason H.S., Celements J.D., Artzen C.J. (1995). Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science, 268: 714-716.
9. Harashima S. (1994). Heterologous protein production by yeast host-vector systems. Bioprocess Technol., 19: 137-158.
10. Hill J., Donald K.A., Griffiths D.E., Donald G. (1991). DMSO-enhanced whole cell yeast transformation. Nucleic Acids Res., 19: 5791.
11. Hirts T.R., Holmgren J. (1987). Conformation of protein secreted across bacterial outer membranes: a study of enterotoxin translocation from Vibrio cholerae. Proc. Acad. Sci., 84: 7418-7422.
12. Hoffman C.S., Winston F.A. (1987). Ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene, 57: 267-272.
13. Holmgren J., Svnnerholm A.M. (1994). Mechanisms of disease and immunity in Cholera. J. Infct. Dis., 136: 105-112.
14. Jani D., Meena L.S., Rizwan-ul Haq Q.M., Yogendra S., Sharma A., Tyagi A.K. (2002). Expression of cholera toxin B subunit in transgenic tomato plants. Trans. Res., 11: 447-454.
15. Jertborn M., Nordstrom I., Kilander A., Czerkinsky C., Holmgren J. (2001). Local and systemic immune responses to rectal administration of Cholera toxin B subunit in humans. Infect. Immun., 69: 4125-4128.
16. Jertborn M., Svennerholm A.M., Holmgren K. (1994). Immunological memory after immunization with oral Cholera B subunit-whole-cell vaccine in Swedish volunteers. Vaccine, 12: 1078-1082.
17. Jetborn M., Sevennerholm A.M., Holmgren J. (1988). Five year immunological memory in Swedish volunteers after oral Cholera vaccination. J. Infect. Dis., 157: 374-376.
18. Lebens M., Shahabi V., Backstrom M., Hoze T., Lindbland M., Holmgren J. (1996). Synthesis of hybrid molecules between heat-labile enterotoxin and Cholera toxin B subunit: potential for use in a broad-spectrum vaccine. Infect. Immun., 64: 2144-2150.
19. Lonnroth I., Holmgren J. (1973). Subunit structure of Cholera toxin. J. Gen. Microbiol., 76: 417-427.
20. Pines O., London A. (1991). Expression and secretion of Staphylococcus nuclease A in yeast: effects of amino terminal sequences. J. Gen. Microbiol., 137: 771-778.
21. Psomas E., Andrighetto C., Tzanettaki E.L., Lombardi A., Tzanetakis N. (2002). Some probiotic properties of yeast isolates from infant faces and Feta cheese. Int. J. Food Microbiol., 69: 123-125.
22. Ricci S., Medaglini D., Rush C.M., Marcello A., Peppoloni S., Manganelli R., Palú G., Pozzi G. (2000). Immunogenicity of the B monomer of Escherichia coli heat-labile toxin expressed on the surface of Streptococcus gordonii. Infect. Immun., 68: 760-766.
23. Rodríguez V.M., Montero C., Machado H., Joglar M. (2002). The evaluation of yeast derivatives as adjuvants for the immune response to the Bm86 antigen in cattle. BMC Biotechnol., 1: 2.
24. Sack D.A., Nair G.B. Siddique A.K. (2004). Cholera. The Lancet, 363: 223-233.
25. rd edn., Coldsping Harbor laboratory Press, New York.
26. Schonberger O., Hirst T.R., Pines O. (1991). Targeting and assembly of an oligomeric bacterial enterotoxoid in the endoplasmic reticulum of Saccharomyces cerevisiae. Mol. Microbiol., 5: 2663-2671.
27. Song H., Zhou L., Fang W., Li Y., Wang X., Fang H., Li X., Wu M., Qiu B. (2004). High-level expression of codon optimized foot-and-mouth disease virus complex epitopes and cholera toxin B subunit chimera in Hansenula polymorpha. Biochem. Biophys. Res. Co., 315: 235-239.
28. Spangler B.D. (1992). Structure and function of Cholera toxin and the related heat-labile enterotoxin of Escherichia coli. Microbiol. Rev., 56: 622-647.
29. Stubbs A.C., Martin K.S., Coeshott C., Skaates S.V., Kuritzkes D.R., Bellgrau D., Franzusoff A., Duke R.C., Wilson C.C. (2001). Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity. Nature Med., 7: 625-629.
30. Stubbs A.C., Wilson C.C. (2002). Recombinant yeast as a vaccine vector for the induction of cytotxic T-lymphocyte responses. Curr. Opin. Mol. Ther., 4: 35-40.
31. Sun J.B., Rask C., Olsson T., Holmgren J., Czerkinsky C. (1996). Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to Cholera toxin B subunit. Proc. Natl Acad. Sci. USA, 92: 3358-3361.
32. Takahashi H.K., Jackson R.J., Fujihashi K., Staats H.F., Hamada S., Clements J.D., Bost K.L., McGhee J.R. (1996). Epitope maps of the Escherichia coli heat-labile toxin B subunit for development of a synthetic oral vaccine. Infect. Immun., 64: 1290-1298.
33. Tochikubo K., Yasuda Y. (2000). Principles of mucosal immunity and development of mucosal vaccines using Cholera toxin B subunit and its related adjuvants. Rec. Res. Devel. Microbiol., 4: 387-405.
34. Yu J., Langridge W.H. (2000). Novel approaches to oral vaccines: delivery of antigens by edible plants. Curr. Infect. Dis. Rep., 2: 73-77
35. Yu P., Neamati N., Tarasov S., He Q., Sheikh M.S., Wang Y.X. (2004). Codon-optimized cloning, expression and characterization of the C-terminal region of human apoptotic protein